Buckley Wealth Management LLC bought a new position in Monsanto (NYSE:MON) in the 4th quarter, HoldingsChannel.com reports. The fund bought 3,180 shares of the basic materials company’s stock, valued at approximately $371,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Scotia Capital Inc. grew its position in shares of Monsanto by 1.6% in the 2nd quarter. Scotia Capital Inc. now owns 3,765 shares of the basic materials company’s stock worth $446,000 after acquiring an additional 60 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Monsanto by 10.2% in the 3rd quarter. Parkside Financial Bank & Trust now owns 4,865 shares of the basic materials company’s stock worth $583,000 after acquiring an additional 452 shares in the last quarter. Laurel Wealth Advisors Inc. grew its position in shares of Monsanto by 12.2% in the 3rd quarter. Laurel Wealth Advisors Inc. now owns 4,166 shares of the basic materials company’s stock worth $499,000 after acquiring an additional 453 shares in the last quarter. Zions Bancorporation grew its position in shares of Monsanto by 18.2% in the 3rd quarter. Zions Bancorporation now owns 3,184 shares of the basic materials company’s stock worth $381,000 after acquiring an additional 491 shares in the last quarter. Finally, Yorkville Capital Management LLC grew its position in shares of Monsanto by 2.7% in the 2nd quarter. Yorkville Capital Management LLC now owns 18,800 shares of the basic materials company’s stock worth $2,225,000 after acquiring an additional 500 shares in the last quarter. Institutional investors own 74.62% of the company’s stock.

Monsanto (NYSE:MON) opened at $120.44 on Tuesday. Monsanto has a 12-month low of $106.97 and a 12-month high of $123.15. The stock has a market capitalization of $53,100.00, a P/E ratio of 22.26, a P/E/G ratio of 1.70 and a beta of 1.01. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28.

Monsanto (NYSE:MON) last released its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The company had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. During the same quarter in the prior year, the firm earned $0.21 EPS. The company’s revenue for the quarter was up .3% compared to the same quarter last year. equities analysts forecast that Monsanto will post 5.76 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, April 6th will be given a dividend of $0.54 per share. The ex-dividend date is Thursday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.79%. Monsanto’s dividend payout ratio is currently 39.93%.

In related news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.70% of the company’s stock.

MON has been the subject of several research reports. Royal Bank of Canada reiterated a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research report on Wednesday, November 15th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Deutsche Bank reiterated a “buy” rating on shares of Monsanto in a research report on Tuesday, January 16th. Finally, Wells Fargo & Co restated a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a research report on Wednesday, January 17th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $127.30.

COPYRIGHT VIOLATION WARNING: “Buckley Wealth Management LLC Takes $371,000 Position in Monsanto (MON)” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://theolympiareport.com/2018/02/13/buckley-wealth-management-llc-takes-371000-position-in-monsanto-mon.html.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.